•
Jun 30, 2024

REGENXBIO Q2 2024 Earnings Report

Total Revenue
$22.3M
Previous year: $20M
+11.6%
EPS
-$1.05
Previous year: -$1.66
-36.7%
Gross Profit
$7.67M
Previous year: $10.5M
-27.0%
Cash and Equivalents
$290M
Previous year: $68.6M
+323.3%
Free Cash Flow
-$46M
Previous year: -$49.9M
-7.9%
Total Assets
$569M
Previous year: $682M
-16.6%

REGENXBIO

REGENXBIO